COVID-19 Antiviral Medication Use Among Pregnant and Recently Pregnant US Outpatients.

ABSTRACT:

Background

Pregnant people are at risk of severe coronavirus disease 2019 (COVID-19) and associated complications. While withholding treatment from pregnant patients is not recommended, little is known about the frequency of antiviral medication use during pregnancy.

Methods

Using Medicaid and commercial insurance databases, we constructed a national claims-based cohort study of pregnant, recently pregnant, and nonpregnant female patients 18-49 years old with an outpatient diagnosis of COVID-19 between 21 December 2021 and 30 September 2022. Outpatient treatment with a recommended antiviral medication was identified within 5 days of diagnosis, using national drug codes in outpatient prescription drug claims. Propensity score-matched prevalence ratios (PRs) were used to compa

SUBMITTER: Regan AK 

PROVIDER: S-EPMC11912976 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature